<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Chin Med J (Engl)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Chin. Med. J</journal-id>
      <journal-id journal-id-type="publisher-id">CMJ</journal-id>
      <journal-title-group>
        <journal-title>Chinese Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0366-6999</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26609000</article-id>
      <article-id pub-id-type="pmc">4795258</article-id>
      <article-id pub-id-type="publisher-id">CMJ-128-3120</article-id>
      <article-id pub-id-type="doi">10.4103/0366-6999.169171</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Euthyrox Induced Drug Rash in an Aged Patient</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>Rui</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Jun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Shi</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Allergy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China</aff>
      <aff id="aff2"><label>2</label>Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Ministry of Health Key Laboratory of Endocrinology, Beijing 100730, China</aff>
      <author-notes>
        <corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Shi Chen, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Ministry of Health Key Laboratory of Endocrinology, Beijing 100730, China E-Mail: <email xlink:href="cs0083@126.com">cs0083@126.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>20</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <volume>128</volume>
      <issue>22</issue>
      <fpage>3120</fpage>
      <lpage>3120</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2015 Chinese Medical Journal</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>To the Editor: A 65-year-old woman was admitted to Peking Union Medical College Hospital because of rash with pruritus for 1 month after taking Euthyrox. Rash attacked without other symptoms 20 days after she took Euthyrox 50 &#x3BC;g once a day and aggravated when Euthyrox was continued for the next 2 days. The past history included partial thyroidectomy for hyperthyroidism in 1982; tuberculosis in 1990; hypertension in 2009, and cerebral hemorrhage in 2010. It was noted that the patient occurred fever and vomiting 2&#x2013;3 days after antituberculosis therapy, and the symptoms alleviated 3 days after rifampicin withdrawal. Penicillin skin test was positive. The laboratory examination showed thyroid-stimulating hormone 8.78 &#x3BC;U/ml (normal range: 0.38&#x2013;4.34 &#x3BC;U/ml), T3, T4, FT3, and FT4 were normal, which suggested subclinical hypothyroidism. Patch test of Euthyrox was probable positive to 25&#x2013;50 &#x3BC;g and positive to 100&#x2013;150 &#x3BC;g at 48&#x2013;72 h, while only probable positive to letrox 150 &#x3BC;g. Moreover, patch test of health control showed negative. Prick test was negative of two drugs. Hence, drug rash induced by Euthyrox was diagnosed according to the laboratory test results. The condition was stable 1 week after discontinuation of Euthyrox and rash disappeared completely after 1 month. Thyroid function returned to normal 4 months after taking Letrox and no rash reappeared.</p>
    <p>Levothyroxine substitutive therapy is widely used for hypothyroidism. Hypothyroidism prevalence is approximately 1:1000 in males and 4:1000 in females, and up to 10% of the population may have subclinical hypothyroidism.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Trade name of levothyroxine includes Euthyrox (Merck KGaA, Darmstadt, Germany) and Letrox (Berlin Chemie, Berlin, Germany), and another substitution in China. Rash induced by levothyroxine is rare and may be caused by drug ingredient or adjuvant. Hence, the differentiation of real cause for allergic reaction is important for further treatment.</p>
    <p>Rash attacked after taking Euthyrox, aggravated during drug continued, and alleviated after drug withdraws, so Euthyrox induced drug rash was diagnosed according to Naranjo scoring method.[<xref rid="ref3" ref-type="bibr">3</xref>] Type IV allergic reaction was indicated for the medical history. Challenge test was avoided because of complex basic diseases.</p>
    <p>Broadly speaking, <italic>in vivo</italic> allergen tests include patch test and skin test. Type IV allergic reaction is usually checked by patch test. Skin test includes prick test and intracutaneous test, which shows Type I allergic reaction. Prick test is more secure than intracutaneous test for damaging epidermis and trace allergen.</p>
    <p>According to patch test and prick test of Euthyrox and Letrox, allergic to Euthyrox and not to Letrox was confirmed. The patient received the treatment of Letrox, no rash appeared and thyroid function returned to normal 4 months later, thereby avoid desensitization.[<xref rid="ref4" ref-type="bibr">4</xref>]</p>
    <sec disp-level="2" id="sec2-1">
      <title>Financial support and sponsorship</title>
      <p>Nil.</p>
    </sec>
    <sec disp-level="2" id="sec2-2">
      <title>Conflicts of interest</title>
      <p>There are no conflicts of interest.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="edited-by">
        <p><bold>Edited by:</bold> Xin Chen</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>R<sc>EFERENCES</sc></title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooper</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Clinical practice. Subclinical hypothyroidism</article-title>
          <source>N Engl J Med</source>
          <year>2001</year>
          <volume>345</volume>
          <fpage>260</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">11474665</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Ladenson</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>Hypothyroidism</article-title>
          <source>Lancet</source>
          <year>2004</year>
          <volume>363</volume>
          <fpage>793</fpage>
          <lpage>803</lpage>
          <pub-id pub-id-type="pmid">15016491</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naranjo</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Busto</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Sellers</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sandor</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ruiz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A method for estimating the probability of adverse drug reactions</article-title>
          <source>Clin Pharmacol Ther</source>
          <year>1981</year>
          <volume>30</volume>
          <fpage>239</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">7249508</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fevzi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mustafa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ozgur</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cetin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Abdullah</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sait</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Successful oral desensitization to levothyroxine</article-title>
          <source>Ann Allergy Asthma Immunol</source>
          <year>2013</year>
          <volume>111</volume>
          <fpage>146</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">23886239</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
